Professor Philip S. Low

Purdue Center for Drug Discovery

Purdue Centre for Drug Discovery Targeting Tumors with Engineered T-Cell Therapy

Director of the Purdue Center for Drug Discovery, Professor Philip S. Low, explains how advances in engineered T-cell therapy allow him to target tumors with improved selectivity, sensitivity and control, for enabling enhanced cancer immunotherapy.

LIKE 0


Professor Philip S. Low
Cancer Research Precision Medicine

Professor Philip S. Low

Biography

Professor Philip S. Low is Director of the Purdue Center for Drug Discovery. More

Professor Philip S. Low

Purdue Center for Drug Discovery

Professor Philip S. Low is Director of the Purdue Center for Drug Discovery - Biochemistry (Department of Chemistry). his laboratory focuses primarily on the development of ligand-targeted imaging and therapeutic agents for the diagnosis and treatment of important human diseases.